Decentralized INR study
Completed
- Conditions
- het betreft patiënten die op de afdeling cardiologie behandeld worden met antistollingsmiddelen ter preventie van trombotische aandoeningendiep vein thrombosispreventionpulmonary embolismthrombosis
- Registration Number
- NL-OMON36026
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1036
Inclusion Criteria
Treated with anticoagulation medication
Inpatient in cardiology department
Exclusion Criteria
No fingers available for fingerprick
Terminally ill
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Using error grid analysis1 a maximal allowable bias of 20% between the<br /><br>reference method and another INR assay will be allowed. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Discrepancies between assays will be investigated by measuring coagulation<br /><br>factor levels and, if present, the anti-Xa activity due to the presence of<br /><br>heparin or LMWH.</p><br>